Compare Tango Therapeutics Inc. (TNGX) vs Vanguard Information Technology Index Fund ETF (VGT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tango Therapeutics Inc. vs Vanguard Information Technology Index Fund ETF — how do they compare? Tango Therapeutics Inc. trades at $22.5 (market cap $3.74B), while Vanguard Information Technology Index Fund ETF trades at $121.67 (market cap $170.20B). The key difference: Vanguard Information Technology Index Fund ETF is far larger — about 45.5× Tango Therapeutics Inc.'s market cap, and Vanguard Information Technology Index Fund ETF is trading nearer its 52-week high, Tango Therapeutics Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tango Therapeutics Inc. for 0 Days and Vanguard Information Technology Index Fund ETF for 130 Days on average.
| TNGX | VGT | |
|---|---|---|
Market Cap | $3.74B | $170.20B |
Volume | 3,438,781 | 6,852,336 |
Sector | Health | — |
52-Week High | $32.90 | $129.79 |
52-Week Low | $7.50 | $83.59 |
Typical Hold Time | 0 Days | 130 Days |
Enterprise Value | $2.76B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
VGT trades at $126.48, down slightly by 0.02% today, but maintains a bullish technical stance with strong moving average signals. The ETF, focused on U.S. technology stocks, has delivered robust historical returns, with recent news highlighting its low expense ratio and concentration in top tech giants like Nvidia, Apple, and Microsoft. A dividend of $0.15 is scheduled for late September 2026.
The outlook for VGT remains positive given technology sector growth and AI-driven momentum, though risks include sector concentration and valuation sensitivity. Investor sentiment is buoyed by strong past performance and institutional inflows, but macroeconomic shifts could pose headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →About Vanguard Information Technology Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index/Information Technology 25/50, an index made up of stocks of large, mid-size, and small US companies within the information technology sector, as classified under the GICS. The advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VGT →
